EEF1A2 SiRNA Suppresses MPP-Induced Activation of Akt and MTOR and Potentiates Caspase-3 Activation in a Parkinson's Disease Model

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2023 Apr 13

PMID 37051183

Authors

Kawinthra Khwanraj

Athinan Prommahom

Permphan Dharmasaroja

Affiliations

Soon will be listed here.

Abstract

The tissue-specific protein eEF1A2 has been linked to the development of neurological disorders. The role of eEF1A2 in the pathogenesis of Parkinson's disease (PD) has yet to be investigated. The aim of this study was to determine the potential neuroprotective effects of eEF1A2 in an MPP model of PD. Differentiated SH-SY5Y cells were transfected with eEF1A2 siRNA, followed by MPP exposure. The expression of p-Akt1 and p-mTORC1 was determined using Western blotting. The expression of p53, Bax, Bcl-2, and caspase-3 was evaluated using qRT-PCR. Cleaved caspase-3 levels and Annexin V/propidium iodide flow cytometry were used to determine apoptosis. The effects of PI3K inhibition were examined. The results showed that eEF1A2 siRNA significantly reduced the eEF1A2 expression induced by MPP. MPP treatment activated Akt1 and mTORC1; however, eEF1A2 knockdown suppressed this activation. In eEF1A2-knockdown cells, MPP treatment increased the expression of p53 and caspase-3 mRNA levels as well as increased apoptotic cell death when compared to MPP treatment alone. In cells exposed to MPP, upstream inhibition of the Akt/mTOR pathway, by either LY294002 or wortmannin, inhibited the phosphorylation of Akt1 and mTORC1. Both PI3K inhibitors increased eEF1A2 expression in cells, whether or not they were also treated with MPP. In conclusion, eEF1A2 may function as a neuroprotective factor against MPP, in part by regulating the Akt/mTOR pathway upstream.

References

Lehmann S, Seve M, Vanwonterghem L, Michelland S, Cunin V, Coll J . A large scale proteome analysis of the gefitinib primary resistance overcome by KDAC inhibition in KRAS mutated adenocarcinoma cells overexpressing amphiregulin. J Proteomics. 2019; 195:114-124. DOI: 10.1016/j.jprot.2019.01.009. View

Khwanraj K, Phruksaniyom C, Madlah S, Dharmasaroja P . Differential Expression of Tyrosine Hydroxylase Protein and Apoptosis-Related Genes in Differentiated and Undifferentiated SH-SY5Y Neuroblastoma Cells Treated with MPP(.). Neurol Res Int. 2015; 2015:734703. PMC: 4655072. DOI: 10.1155/2015/734703. View

Guertin D, Sabatini D . Defining the role of mTOR in cancer. Cancer Cell. 2007; 12(1):9-22. DOI: 10.1016/j.ccr.2007.05.008. View

Amiri A, Noei F, Jeganathan S, Kulkarni G, Pinke D, Lee J . eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration. Oncogene. 2006; 26(21):3027-40. DOI: 10.1038/sj.onc.1210101. View

Perez-Alvarez M, Villa Gonzalez M, Benito-Cuesta I, Wandosell F . Role of mTORC1 Controlling Proteostasis after Brain Ischemia. Front Neurosci. 2018; 12:60. PMC: 5818460. DOI: 10.3389/fnins.2018.00060. View

Zou Z, Chen J, Liu A, Zhou X, Song Q, Jia C . mTORC2 promotes cell survival through c-Myc-dependent up-regulation of E2F1. J Cell Biol. 2015; 211(1):105-22. PMC: 4602034. DOI: 10.1083/jcb.201411128. View

Newbery H, Gillingwater T, Dharmasaroja P, Peters J, Wharton S, Thomson D . Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor. J Neuropathol Exp Neurol. 2005; 64(4):295-303. DOI: 10.1093/jnen/64.4.295. View

Anand N, Murthy S, Amann G, Wernick M, Porter L, Cukier I . Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet. 2002; 31(3):301-5. DOI: 10.1038/ng904. View

Xicoy H, Wieringa B, Martens G . The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Mol Neurodegener. 2017; 12(1):10. PMC: 5259880. DOI: 10.1186/s13024-017-0149-0. View

10.

Worst T, Waldbillig F, Abdelhadi A, Weis C, Gottschalt M, Steidler A . The EEF1A2 gene expression as risk predictor in localized prostate cancer. BMC Urol. 2017; 17(1):86. PMC: 5604352. DOI: 10.1186/s12894-017-0278-3. View

11.

Martins J, Bastos M, Carvalho F, Capela J . Differential Effects of Methyl-4-Phenylpyridinium Ion, Rotenone, and Paraquat on Differentiated SH-SY5Y Cells. J Toxicol. 2013; 2013:347312. PMC: 3654346. DOI: 10.1155/2013/347312. View

12.

Quesada A, Lee B, Micevych P . PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev Neurobiol. 2008; 68(5):632-44. PMC: 2667142. DOI: 10.1002/dneu.20609. View

13.

Kahns S, Lund A, Kristensen P, Knudsen C, Clark B, Cavallius J . The elongation factor 1 A-2 isoform from rabbit: cloning of the cDNA and characterization of the protein. Nucleic Acids Res. 1998; 26(8):1884-90. PMC: 147499. DOI: 10.1093/nar/26.8.1884. View

14.

Chen Y, Monteith N, Law P, Loh H . Dynamic association of p300 with the promoter of the G protein-coupled rat delta opioid receptor gene during NGF-induced neuronal differentiation. Biochem Biophys Res Commun. 2010; 396(2):294-8. DOI: 10.1016/j.bbrc.2010.04.083. View

15.

Wirakiat W, Prommahom A, Dharmasaroja P . Inhibition of the antioxidant enzyme PRDX1 activity promotes MPP-induced death in differentiated SH-SY5Y cells and may impair its colocalization with eEF1A2. Life Sci. 2020; 258:118227. DOI: 10.1016/j.lfs.2020.118227. View

16.

Prommahom A, Dharmasaroja P . Effects of eEF1A2 knockdown on autophagy in an MPP-induced cellular model of Parkinson's disease. Neurosci Res. 2020; 164:55-69. DOI: 10.1016/j.neures.2020.03.013. View

17.

Akiyama H, Kamiguchi H . Phosphatidylinositol 3-kinase facilitates microtubule-dependent membrane transport for neuronal growth cone guidance. J Biol Chem. 2010; 285(53):41740-8. PMC: 3009901. DOI: 10.1074/jbc.M110.156489. View

18.

Gao G, Duan Y, Chang F, Zhang T, Huang X, Yu C . METTL14 promotes apoptosis of spinal cord neurons by inducing EEF1A2 m6A methylation in spinal cord injury. Cell Death Discov. 2022; 8(1):15. PMC: 8748977. DOI: 10.1038/s41420-021-00808-2. View

19.

Xu C, Hu D, Zhu Q . eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation. Clin Exp Metastasis. 2013; 30(7):933-44. DOI: 10.1007/s10585-013-9593-6. View

20.

Sha Z, Brill L, Cabrera R, Kleifeld O, Scheliga J, Glickman M . The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol Cell. 2009; 36(1):141-52. PMC: 2789680. DOI: 10.1016/j.molcel.2009.09.026. View